Supporting Risk Assessment, Increasing Pharma Raw Materials Know-How
With the ever increasing regulatory challenges drug manufacturers are facing, collecting information for your risk assessment can be costly and time-consuming. For its 10th anniversary, we have expanded our EMPROVE® regulatory documentation to offer you even more support for your risk assessment. What's new?:
Supply chain information supports transparency
New Product Quality Reports inform about the consistency of our products.
Information on elemental impurity levels of EMPROVE® products step by step/product by product
With a portfolio of 400 EMPROVE® raw materials, Merck Millipore helps you obtain standardized qualification documentation you need to smoothen your qualification and approval processes.
Facilitating risk assessment
Speed approval preparation for faster time to market
Time and money savings
Create formulations with full regulatory compliance
Merck Millipore's EMPROVE® portfolio includes the following product lines:
EMPROVE® api: For use as an active pharmaceutical ingredient
Our EMPROVE® dossiers comprise detailed, usage-specific documentation that includes information on manufacturing, test methods, purity and stability data, helping you to successfully navigate regulatory challenges.